23 03 2020

Novel coronavirus: top-level vaccine research from the German Southwest

Researchers around the world are working feverishly to develop vaccines and therapies against the novel coronavirus. Top-level research from Baden-Württemberg is providing promising approaches.

CureVac, a company from Tübingen, Baden-Württemberg, is carrying the hopes in the fight against the novel coronavirus. The biopharmaceutical company is working under high pressure to produce a vaccine against the coronavirus in order to help and protect people and patients worldwide. The researchers use the natural messenger substance mRNA in order to develop a particularly economical and therefore gentle means of preventing Covid-19. During a videoconference with CureVac, Winfried Kretschmann, Minister-President of Baden-Württemberg, expressed his pleasure and gratitude to have such an innovative company in the German Southwest and promised the utmost political support.

Further information on Healthcare industry BW (in English)

Read the complete news item here (in German)


In addition to that, the Ministry of Economic Affairs, Labour and Housing is supporting corona research at the Natural and Medical Sciences Institute (NMI) in Reutlingen with 210,000 euros for high-throughput robotics that will be used to investigate the immune response to coronavirus infections and identify specific antigens for diagnostics and vaccine development. "We must now do everything we can to find a suitable vaccine against the corona virus as quickly as possible. The industry-driven research in our state can make a valuable contribution to this," said Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labour and Housing. The NMI focuses on the development of biomarkers for medical research and clinical diagnostics. Due to this special competence, the institute is part of an international consortium on coronavirus research funded by the European Union. The project requires a high number of sample measurements to be carried out quickly and efficiently, for which high-throughput robotics is urgently needed.

Further information from the NMI on the investigation of COVID-19 immunity

Read the full news item here (in German)